ImmunityBio Inc (NASDAQ: IBRX) Has Succeeded In Attracting Investors This Year, The Stock Is Up 4.38% Year-To-Date

ImmunityBio Inc (NASDAQ:IBRX)’s traded shares stood at 4.41 million during the last session, with the company’s beta value hitting 1.19. At the close of trading, the stock’s price was $5.24, to imply an increase of 6.50% or $0.32 in intraday trading. The IBRX share’s 52-week high remains $6.93, putting it -32.25% down since that peak but still an impressive 76.15% since price per share fell to its 52-week low of $1.25. The company has a valuation of $3.53B, with an average of 4.15 million shares over the past 3 months.

ImmunityBio Inc (NASDAQ:IBRX) trade information

After registering a 6.50% upside in the last session, ImmunityBio Inc (IBRX) has traded red over the past five days. The stock hit a weekly high of 6.26, jumping 6.50% in its intraday price action. The 5-day price performance for the stock is -12.08%, and 0.19% over 30 days. With these gigs, the year-to-date price performance is 4.38%.

ImmunityBio Inc (IBRX) estimates and forecasts

Looking at statistics comparing ImmunityBio Inc share performance against respective industry, we note that the company has outperformed competitors. ImmunityBio Inc (IBRX) shares are 276.98% up over the last 6 months, with its year-to-date growth rate higher than industry average at 31.31% against 12.80%.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 1.17% for the past 5-year period. While 2024 is set for a 40.87% return in earnings, projections for the next 5 years are at -1.70% annually.

IBRX Dividends

ImmunityBio Inc has its next earnings report out between May 09 and May 13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. ImmunityBio Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.